Laurent Arthaud
Director/Board Member bei CELLECTIS S.A.
Ursprung des Netzwerks ersten Grades von Laurent Arthaud
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
81
| Subsidiary | Investment Managers | 81 |
Ecole Polytechnique
54
| College/University | Other Consumer Services | 54 |
| Public Company | Pharmaceuticals: Major | 37 | |
15
| Public Company | Pharmaceuticals: Major | 15 |
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.
15
| Extinct | Miscellaneous Commercial Services | 15 |
15
| Subsidiary | Miscellaneous Commercial Services | 15 |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France.
14
| Holding Company | Investment Managers | 14 |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.
13
| Holding Company | Biotechnology | 13 |
| Public Company | Pharmaceuticals: Major | 12 | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.
11
| Holding Company | Biotechnology | 11 |
Demeter Ventures SA
 Demeter Ventures SA Investment ManagersFinance 123 Investment Managers SA is a Private Equity/Venture Capital firm, a subsidiary of Capucines Capital Partners SAS founded in 2000. 123 Investment Managers SA is headquartered in Grenoble.
10
| Private Company | Investment Managers | 10 |
Aledia SAS
 Aledia SAS Electrical ProductsProducer Manufacturing Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France.
7
| Holding Company | Electrical Products | 7 |
Ribogenics, Inc.
 Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill.
3
| Private Company | Biotechnology | 3 |
Argobio SAS
 Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Aventis Capital
1
| Extinct | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Laurent Arthaud
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
CDC Enterprises, Inc.
 CDC Enterprises, Inc. Electrical ProductsProducer Manufacturing CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL. | Electrical Products | Chairman Chief Investment Officer Corporate Officer/Principal | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Ventech SA
 Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Investment Managers | Private Equity Investor Private Equity Investor | |
Eurazeo Investment Manager - EIM SA
 Eurazeo Investment Manager - EIM SA Investment ManagersFinance Eurazeo Investment Managr - EIM SA (Eurazeo IM) is a Venture Capital firm founded in 1997 by Christophe Bavière and part of the Eurazeo Group. Eurazeo Investment Manager - EIM SA is headquartered in Paris with additional offices in Frankfurt, Shanghai and Seoul. The firm is formerly known as Idinvest Partners SA, former AGF Private Equity SA. | Investment Managers | Investment Committee Member Director/Board Member | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
| INSEAD | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
| THERADIAG | Medical Specialties | Director/Board Member Investor Relations Contact | |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Institut National des Sciences Appliquées de Toulouse | College/University | Undergraduate Degree Undergraduate Degree | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
French-American Chamber of Commerce
 French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Miscellaneous Commercial Services | President Director/Board Member | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Chief Executive Officer | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member President Director/Board Member General Counsel Chief Executive Officer | |
InGen Biosciences SA
 InGen Biosciences SA Medical SpecialtiesHealth Technology InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Analyst | |
CEA-Léti
 CEA-Léti Miscellaneous Commercial ServicesCommercial Services CEA-Leti is a technology research institute located in Grenoble, France. The institute specializes in miniaturization technologies that enable smart, energy-efficient, and secure solutions for various industries. The institute's multidisciplinary teams deliver solid expertise, leveraging world-class pre-industrialization facilities. CEA-Leti tackles critical challenges in healthcare, energy, and digital migration, from sensors to data processing and computing solutions. The institute has a staff of more than 2,000 talents, a portfolio of 3,200 patents, and 11,000 sq. meters of cleanroom space. CEA-Leti has launched 75 startups and is a member of the Carnot Institutes network. Founded in 1967, CEA-Leti pioneers micro and nanotechnologies to provide differentiating applicative solutions for companies, SMEs, and startups. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Amundi Private Equity Funds SA
 Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Investment Managers | Director of Investments Private Equity Investor Private Equity Analyst | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sigfox SA
 Sigfox SA Packaged SoftwareTechnology Services Sigfox SA provides Internet of Things (IoT) services. The firm offers solutions in private area network, geolocation, and connectivity. It serves the agriculture; manufacturing; supply chain and logistics; utilities and energy; retail; and insurance sectors. The company was founded by Christophe Fourtet, Thierry Bailleul, and Ludovic Le Moan in 2009 and is headquartered in Labege, France. | Packaged Software | Director/Board Member Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member | |
| École des Hautes Études Commerciales du Nord | College/University | Undergraduate Degree Graduate Degree | |
| SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Director/Board Member | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Cornovum SASU
 Cornovum SASU Financial ConglomeratesFinance Cornovum SASU is an investment holding French company. The company is based in Paris, France. The company was founded in 2015. The CEO is Maïlys Ferrère. | Financial Conglomerates | Chief Executive Officer Chairman | |
| NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| CELLNOVO | Medical Specialties | Director/Board Member Director of Finance/CFO |
Statistik
International
| Frankreich | 40 |
| Vereinigte Staaten | 9 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
| Schweden | 2 |
Sektoral
| Health Technology | 25 |
| Finance | 11 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 495 |
| Corporate Officer/Principal | 140 |
| Independent Dir/Board Member | 87 |
| Chairman | 76 |
| Private Equity Investor | 68 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jérôme Gallot | 33 |
| Pierre Bastid | 29 |
| Joseph Papa | 28 |
| Mounia Chaoui-Roulleau | 27 |
| Maina Bhaman | 26 |
| Ann Hanham | 26 |
| Steven Gilman | 25 |
| Stéphane Boissel | 24 |
| Philippe Boucheron | 24 |
| Dominique Takizawa | 23 |
| Mathieu Simon | 22 |
| Pamela Kirby | 22 |
| Maïlys Ferrère | 21 |
| Ekaterina Smirnyagina | 21 |
| Marie-Laure Garrigues | 19 |
- Börse
- Insiders
- Laurent Arthaud
- Unternehmensverbindungen
